DNS-3379 vs. Placebo in Stroke Rehabilitation

Summary

This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.

Timeline

Start

2017-11-13

Primary completion

2017-12-31

Completion

2017-12-31

Outcome

Outcome not reported

Stopped: “Administrative”

Drugs

Indications